nodes	percent_of_prediction	percent_of_DWPC	metapath
Dexmedetomidine—CYP1A1—Tretinoin—peripheral nervous system neoplasm	0.162	0.25	CbGbCtD
Dexmedetomidine—CYP1A1—Dacarbazine—peripheral nervous system neoplasm	0.139	0.215	CbGbCtD
Dexmedetomidine—CYP2E1—Dacarbazine—peripheral nervous system neoplasm	0.108	0.166	CbGbCtD
Dexmedetomidine—CYP1A2—Alitretinoin—peripheral nervous system neoplasm	0.0779	0.12	CbGbCtD
Dexmedetomidine—CYP1A2—Dacarbazine—peripheral nervous system neoplasm	0.0623	0.0959	CbGbCtD
Dexmedetomidine—CYP2E1—Etoposide—peripheral nervous system neoplasm	0.0527	0.0811	CbGbCtD
Dexmedetomidine—CYP1A2—Etoposide—peripheral nervous system neoplasm	0.0305	0.0469	CbGbCtD
Dexmedetomidine—CYP2D6—Doxorubicin—peripheral nervous system neoplasm	0.0171	0.0264	CbGbCtD
Dexmedetomidine—Fluid retention—Doxorubicin—peripheral nervous system neoplasm	0.000437	0.00125	CcSEcCtD
Dexmedetomidine—Infection—Dactinomycin—peripheral nervous system neoplasm	0.000435	0.00124	CcSEcCtD
Dexmedetomidine—Arrhythmia—Cisplatin—peripheral nervous system neoplasm	0.000435	0.00124	CcSEcCtD
Dexmedetomidine—Blood urea increased—Doxorubicin—peripheral nervous system neoplasm	0.000435	0.00124	CcSEcCtD
Dexmedetomidine—Abnormal vision—Epirubicin—peripheral nervous system neoplasm	0.000434	0.00124	CcSEcCtD
Dexmedetomidine—Sepsis—Epirubicin—peripheral nervous system neoplasm	0.000432	0.00123	CcSEcCtD
Dexmedetomidine—Convulsion—Alitretinoin—peripheral nervous system neoplasm	0.000431	0.00123	CcSEcCtD
Dexmedetomidine—Hypertension—Alitretinoin—peripheral nervous system neoplasm	0.000429	0.00123	CcSEcCtD
Dexmedetomidine—Thrombocytopenia—Dactinomycin—peripheral nervous system neoplasm	0.000428	0.00122	CcSEcCtD
Dexmedetomidine—Abdominal pain—Topotecan—peripheral nervous system neoplasm	0.000427	0.00122	CcSEcCtD
Dexmedetomidine—Body temperature increased—Topotecan—peripheral nervous system neoplasm	0.000427	0.00122	CcSEcCtD
Dexmedetomidine—Malnutrition—Cisplatin—peripheral nervous system neoplasm	0.000423	0.00121	CcSEcCtD
Dexmedetomidine—Abdominal pain—Isotretinoin—peripheral nervous system neoplasm	0.000423	0.00121	CcSEcCtD
Dexmedetomidine—Abdominal pain—Tretinoin—peripheral nervous system neoplasm	0.000423	0.00121	CcSEcCtD
Dexmedetomidine—Body temperature increased—Tretinoin—peripheral nervous system neoplasm	0.000423	0.00121	CcSEcCtD
Dexmedetomidine—Body temperature increased—Isotretinoin—peripheral nervous system neoplasm	0.000423	0.00121	CcSEcCtD
Dexmedetomidine—Anxiety—Alitretinoin—peripheral nervous system neoplasm	0.000422	0.0012	CcSEcCtD
Dexmedetomidine—Blood alkaline phosphatase increased—Epirubicin—peripheral nervous system neoplasm	0.000415	0.00119	CcSEcCtD
Dexmedetomidine—Convulsion—Vincristine—peripheral nervous system neoplasm	0.000415	0.00119	CcSEcCtD
Dexmedetomidine—Dry mouth—Alitretinoin—peripheral nervous system neoplasm	0.000414	0.00118	CcSEcCtD
Dexmedetomidine—Cardiac disorder—Etoposide—peripheral nervous system neoplasm	0.000414	0.00118	CcSEcCtD
Dexmedetomidine—Hypertension—Vincristine—peripheral nervous system neoplasm	0.000413	0.00118	CcSEcCtD
Dexmedetomidine—Hepatic function abnormal—Epirubicin—peripheral nervous system neoplasm	0.000413	0.00118	CcSEcCtD
Dexmedetomidine—Pulmonary oedema—Doxorubicin—peripheral nervous system neoplasm	0.00041	0.00117	CcSEcCtD
Dexmedetomidine—Confusional state—Alitretinoin—peripheral nervous system neoplasm	0.000409	0.00117	CcSEcCtD
Dexmedetomidine—Angiopathy—Etoposide—peripheral nervous system neoplasm	0.000404	0.00116	CcSEcCtD
Dexmedetomidine—Infection—Alitretinoin—peripheral nervous system neoplasm	0.000403	0.00115	CcSEcCtD
Dexmedetomidine—Mediastinal disorder—Etoposide—peripheral nervous system neoplasm	0.000402	0.00115	CcSEcCtD
Dexmedetomidine—Abnormal vision—Doxorubicin—peripheral nervous system neoplasm	0.000401	0.00115	CcSEcCtD
Dexmedetomidine—Chills—Etoposide—peripheral nervous system neoplasm	0.0004	0.00114	CcSEcCtD
Dexmedetomidine—Sepsis—Doxorubicin—peripheral nervous system neoplasm	0.000399	0.00114	CcSEcCtD
Dexmedetomidine—Thrombocytopenia—Alitretinoin—peripheral nervous system neoplasm	0.000397	0.00113	CcSEcCtD
Dexmedetomidine—Tachycardia—Alitretinoin—peripheral nervous system neoplasm	0.000396	0.00113	CcSEcCtD
Dexmedetomidine—Hyperhidrosis—Alitretinoin—peripheral nervous system neoplasm	0.000392	0.00112	CcSEcCtD
Dexmedetomidine—Anaemia—Cisplatin—peripheral nervous system neoplasm	0.000391	0.00112	CcSEcCtD
Dexmedetomidine—Renal failure acute—Epirubicin—peripheral nervous system neoplasm	0.000391	0.00112	CcSEcCtD
Dexmedetomidine—Infection—Vincristine—peripheral nervous system neoplasm	0.000388	0.00111	CcSEcCtD
Dexmedetomidine—Blood alkaline phosphatase increased—Doxorubicin—peripheral nervous system neoplasm	0.000384	0.0011	CcSEcCtD
Dexmedetomidine—Thrombocytopenia—Vincristine—peripheral nervous system neoplasm	0.000383	0.00109	CcSEcCtD
Dexmedetomidine—Hepatic function abnormal—Doxorubicin—peripheral nervous system neoplasm	0.000382	0.00109	CcSEcCtD
Dexmedetomidine—Hypotension—Alitretinoin—peripheral nervous system neoplasm	0.000379	0.00108	CcSEcCtD
Dexmedetomidine—Hyperhidrosis—Vincristine—peripheral nervous system neoplasm	0.000378	0.00108	CcSEcCtD
Dexmedetomidine—Pain—Dactinomycin—peripheral nervous system neoplasm	0.000374	0.00107	CcSEcCtD
Dexmedetomidine—Hypoglycaemia—Epirubicin—peripheral nervous system neoplasm	0.00037	0.00106	CcSEcCtD
Dexmedetomidine—Diarrhoea—Topotecan—peripheral nervous system neoplasm	0.000369	0.00105	CcSEcCtD
Dexmedetomidine—Convulsion—Cisplatin—peripheral nervous system neoplasm	0.000367	0.00105	CcSEcCtD
Dexmedetomidine—Diarrhoea—Tretinoin—peripheral nervous system neoplasm	0.000366	0.00105	CcSEcCtD
Dexmedetomidine—Diarrhoea—Isotretinoin—peripheral nervous system neoplasm	0.000366	0.00105	CcSEcCtD
Dexmedetomidine—Hypotension—Vincristine—peripheral nervous system neoplasm	0.000365	0.00104	CcSEcCtD
Dexmedetomidine—Renal failure acute—Doxorubicin—peripheral nervous system neoplasm	0.000362	0.00103	CcSEcCtD
Dexmedetomidine—Dyspnoea—Alitretinoin—peripheral nervous system neoplasm	0.000362	0.00103	CcSEcCtD
Dexmedetomidine—Diarrhoea—Melphalan—peripheral nervous system neoplasm	0.000361	0.00103	CcSEcCtD
Dexmedetomidine—Somnolence—Alitretinoin—peripheral nervous system neoplasm	0.000361	0.00103	CcSEcCtD
Dexmedetomidine—Feeling abnormal—Dactinomycin—peripheral nervous system neoplasm	0.000361	0.00103	CcSEcCtD
Dexmedetomidine—Anxiety—Cisplatin—peripheral nervous system neoplasm	0.000359	0.00103	CcSEcCtD
Dexmedetomidine—Anaemia—Etoposide—peripheral nervous system neoplasm	0.000359	0.00102	CcSEcCtD
Dexmedetomidine—Gastrointestinal pain—Dactinomycin—peripheral nervous system neoplasm	0.000358	0.00102	CcSEcCtD
Dexmedetomidine—Dizziness—Topotecan—peripheral nervous system neoplasm	0.000357	0.00102	CcSEcCtD
Dexmedetomidine—Dizziness—Tretinoin—peripheral nervous system neoplasm	0.000354	0.00101	CcSEcCtD
Dexmedetomidine—Dizziness—Isotretinoin—peripheral nervous system neoplasm	0.000354	0.00101	CcSEcCtD
Dexmedetomidine—Gastrointestinal disorder—Alitretinoin—peripheral nervous system neoplasm	0.00035	0.001	CcSEcCtD
Dexmedetomidine—Pain—Alitretinoin—peripheral nervous system neoplasm	0.000347	0.000991	CcSEcCtD
Dexmedetomidine—Constipation—Alitretinoin—peripheral nervous system neoplasm	0.000347	0.000991	CcSEcCtD
Dexmedetomidine—Abdominal pain—Dactinomycin—peripheral nervous system neoplasm	0.000346	0.000988	CcSEcCtD
Dexmedetomidine—Body temperature increased—Dactinomycin—peripheral nervous system neoplasm	0.000346	0.000988	CcSEcCtD
Dexmedetomidine—Cardiac arrest—Epirubicin—peripheral nervous system neoplasm	0.000343	0.000981	CcSEcCtD
Dexmedetomidine—Infection—Cisplatin—peripheral nervous system neoplasm	0.000343	0.000981	CcSEcCtD
Dexmedetomidine—Vomiting—Topotecan—peripheral nervous system neoplasm	0.000343	0.00098	CcSEcCtD
Dexmedetomidine—Hypoglycaemia—Doxorubicin—peripheral nervous system neoplasm	0.000342	0.000978	CcSEcCtD
Dexmedetomidine—Vomiting—Isotretinoin—peripheral nervous system neoplasm	0.00034	0.000972	CcSEcCtD
Dexmedetomidine—Vomiting—Tretinoin—peripheral nervous system neoplasm	0.00034	0.000972	CcSEcCtD
Dexmedetomidine—Rash—Topotecan—peripheral nervous system neoplasm	0.00034	0.000972	CcSEcCtD
Dexmedetomidine—Dermatitis—Topotecan—peripheral nervous system neoplasm	0.00034	0.000971	CcSEcCtD
Dexmedetomidine—Thrombocytopenia—Cisplatin—peripheral nervous system neoplasm	0.000338	0.000967	CcSEcCtD
Dexmedetomidine—Headache—Topotecan—peripheral nervous system neoplasm	0.000338	0.000966	CcSEcCtD
Dexmedetomidine—Rash—Tretinoin—peripheral nervous system neoplasm	0.000337	0.000964	CcSEcCtD
Dexmedetomidine—Rash—Isotretinoin—peripheral nervous system neoplasm	0.000337	0.000964	CcSEcCtD
Dexmedetomidine—Gastrointestinal disorder—Vincristine—peripheral nervous system neoplasm	0.000337	0.000964	CcSEcCtD
Dexmedetomidine—Tachycardia—Cisplatin—peripheral nervous system neoplasm	0.000337	0.000964	CcSEcCtD
Dexmedetomidine—Dermatitis—Tretinoin—peripheral nervous system neoplasm	0.000337	0.000963	CcSEcCtD
Dexmedetomidine—Dermatitis—Isotretinoin—peripheral nervous system neoplasm	0.000337	0.000963	CcSEcCtD
Dexmedetomidine—Convulsion—Etoposide—peripheral nervous system neoplasm	0.000336	0.00096	CcSEcCtD
Dexmedetomidine—Vomiting—Melphalan—peripheral nervous system neoplasm	0.000336	0.00096	CcSEcCtD
Dexmedetomidine—Headache—Isotretinoin—peripheral nervous system neoplasm	0.000335	0.000958	CcSEcCtD
Dexmedetomidine—Headache—Tretinoin—peripheral nervous system neoplasm	0.000335	0.000958	CcSEcCtD
Dexmedetomidine—Hypertension—Etoposide—peripheral nervous system neoplasm	0.000335	0.000957	CcSEcCtD
Dexmedetomidine—Feeling abnormal—Alitretinoin—peripheral nervous system neoplasm	0.000334	0.000955	CcSEcCtD
Dexmedetomidine—Constipation—Vincristine—peripheral nervous system neoplasm	0.000334	0.000955	CcSEcCtD
Dexmedetomidine—Pain—Vincristine—peripheral nervous system neoplasm	0.000334	0.000955	CcSEcCtD
Dexmedetomidine—Hyperhidrosis—Cisplatin—peripheral nervous system neoplasm	0.000334	0.000955	CcSEcCtD
Dexmedetomidine—Rash—Melphalan—peripheral nervous system neoplasm	0.000333	0.000952	CcSEcCtD
Dexmedetomidine—Dermatitis—Melphalan—peripheral nervous system neoplasm	0.000333	0.000951	CcSEcCtD
Dexmedetomidine—Gastrointestinal pain—Alitretinoin—peripheral nervous system neoplasm	0.000332	0.000948	CcSEcCtD
Dexmedetomidine—Hypokalaemia—Epirubicin—peripheral nervous system neoplasm	0.000329	0.000939	CcSEcCtD
Dexmedetomidine—Aspartate aminotransferase increased—Epirubicin—peripheral nervous system neoplasm	0.000325	0.000929	CcSEcCtD
Dexmedetomidine—Hypotension—Cisplatin—peripheral nervous system neoplasm	0.000323	0.000923	CcSEcCtD
Dexmedetomidine—Abdominal pain—Alitretinoin—peripheral nervous system neoplasm	0.000321	0.000916	CcSEcCtD
Dexmedetomidine—Body temperature increased—Alitretinoin—peripheral nervous system neoplasm	0.000321	0.000916	CcSEcCtD
Dexmedetomidine—Nausea—Topotecan—peripheral nervous system neoplasm	0.00032	0.000916	CcSEcCtD
Dexmedetomidine—Gastrointestinal pain—Vincristine—peripheral nervous system neoplasm	0.00032	0.000913	CcSEcCtD
Dexmedetomidine—Confusional state—Etoposide—peripheral nervous system neoplasm	0.000319	0.000912	CcSEcCtD
Dexmedetomidine—Alanine aminotransferase increased—Epirubicin—peripheral nervous system neoplasm	0.000318	0.00091	CcSEcCtD
Dexmedetomidine—Nausea—Isotretinoin—peripheral nervous system neoplasm	0.000318	0.000908	CcSEcCtD
Dexmedetomidine—Nausea—Tretinoin—peripheral nervous system neoplasm	0.000318	0.000908	CcSEcCtD
Dexmedetomidine—Cardiac arrest—Doxorubicin—peripheral nervous system neoplasm	0.000318	0.000908	CcSEcCtD
Dexmedetomidine—Infection—Etoposide—peripheral nervous system neoplasm	0.000315	0.000899	CcSEcCtD
Dexmedetomidine—Abdominal distension—Epirubicin—peripheral nervous system neoplasm	0.000314	0.000898	CcSEcCtD
Dexmedetomidine—Nausea—Melphalan—peripheral nervous system neoplasm	0.000314	0.000897	CcSEcCtD
Dexmedetomidine—Thrombocytopenia—Etoposide—peripheral nervous system neoplasm	0.00031	0.000886	CcSEcCtD
Dexmedetomidine—Tachycardia—Etoposide—peripheral nervous system neoplasm	0.000309	0.000883	CcSEcCtD
Dexmedetomidine—Abdominal pain—Vincristine—peripheral nervous system neoplasm	0.000309	0.000883	CcSEcCtD
Dexmedetomidine—Body temperature increased—Vincristine—peripheral nervous system neoplasm	0.000309	0.000883	CcSEcCtD
Dexmedetomidine—Dyspnoea—Cisplatin—peripheral nervous system neoplasm	0.000308	0.00088	CcSEcCtD
Dexmedetomidine—Hyperhidrosis—Etoposide—peripheral nervous system neoplasm	0.000306	0.000875	CcSEcCtD
Dexmedetomidine—Hypokalaemia—Doxorubicin—peripheral nervous system neoplasm	0.000304	0.000869	CcSEcCtD
Dexmedetomidine—Aspartate aminotransferase increased—Doxorubicin—peripheral nervous system neoplasm	0.000301	0.00086	CcSEcCtD
Dexmedetomidine—Diarrhoea—Dactinomycin—peripheral nervous system neoplasm	0.000299	0.000855	CcSEcCtD
Dexmedetomidine—Gastrointestinal disorder—Cisplatin—peripheral nervous system neoplasm	0.000298	0.000853	CcSEcCtD
Dexmedetomidine—Hypotension—Etoposide—peripheral nervous system neoplasm	0.000296	0.000845	CcSEcCtD
Dexmedetomidine—Pain—Cisplatin—peripheral nervous system neoplasm	0.000296	0.000844	CcSEcCtD
Dexmedetomidine—Alanine aminotransferase increased—Doxorubicin—peripheral nervous system neoplasm	0.000295	0.000842	CcSEcCtD
Dexmedetomidine—Abdominal distension—Doxorubicin—peripheral nervous system neoplasm	0.000291	0.000831	CcSEcCtD
Dexmedetomidine—Feeling abnormal—Cisplatin—peripheral nervous system neoplasm	0.000285	0.000814	CcSEcCtD
Dexmedetomidine—Dyspnoea—Etoposide—peripheral nervous system neoplasm	0.000282	0.000807	CcSEcCtD
Dexmedetomidine—Hyperglycaemia—Epirubicin—peripheral nervous system neoplasm	0.000282	0.000804	CcSEcCtD
Dexmedetomidine—Somnolence—Etoposide—peripheral nervous system neoplasm	0.000281	0.000804	CcSEcCtD
Dexmedetomidine—Pneumonia—Epirubicin—peripheral nervous system neoplasm	0.00028	0.0008	CcSEcCtD
Dexmedetomidine—Vomiting—Dactinomycin—peripheral nervous system neoplasm	0.000278	0.000795	CcSEcCtD
Dexmedetomidine—Diarrhoea—Alitretinoin—peripheral nervous system neoplasm	0.000278	0.000793	CcSEcCtD
Dexmedetomidine—Rash—Dactinomycin—peripheral nervous system neoplasm	0.000276	0.000788	CcSEcCtD
Dexmedetomidine—Gastrointestinal disorder—Etoposide—peripheral nervous system neoplasm	0.000273	0.000781	CcSEcCtD
Dexmedetomidine—Body temperature increased—Cisplatin—peripheral nervous system neoplasm	0.000273	0.000781	CcSEcCtD
Dexmedetomidine—Neuropathy peripheral—Epirubicin—peripheral nervous system neoplasm	0.000273	0.000779	CcSEcCtD
Dexmedetomidine—Constipation—Etoposide—peripheral nervous system neoplasm	0.000271	0.000774	CcSEcCtD
Dexmedetomidine—Pain—Etoposide—peripheral nervous system neoplasm	0.000271	0.000774	CcSEcCtD
Dexmedetomidine—Urinary tract infection—Epirubicin—peripheral nervous system neoplasm	0.00027	0.000773	CcSEcCtD
Dexmedetomidine—Dizziness—Alitretinoin—peripheral nervous system neoplasm	0.000268	0.000766	CcSEcCtD
Dexmedetomidine—Diarrhoea—Vincristine—peripheral nervous system neoplasm	0.000267	0.000764	CcSEcCtD
Dexmedetomidine—Feeling abnormal—Etoposide—peripheral nervous system neoplasm	0.000261	0.000745	CcSEcCtD
Dexmedetomidine—Hyperglycaemia—Doxorubicin—peripheral nervous system neoplasm	0.000261	0.000744	CcSEcCtD
Dexmedetomidine—Nausea—Dactinomycin—peripheral nervous system neoplasm	0.00026	0.000742	CcSEcCtD
Dexmedetomidine—Pneumonia—Doxorubicin—peripheral nervous system neoplasm	0.000259	0.00074	CcSEcCtD
Dexmedetomidine—Gastrointestinal pain—Etoposide—peripheral nervous system neoplasm	0.000259	0.00074	CcSEcCtD
Dexmedetomidine—Dizziness—Vincristine—peripheral nervous system neoplasm	0.000258	0.000738	CcSEcCtD
Dexmedetomidine—Vomiting—Alitretinoin—peripheral nervous system neoplasm	0.000258	0.000737	CcSEcCtD
Dexmedetomidine—Rash—Alitretinoin—peripheral nervous system neoplasm	0.000256	0.000731	CcSEcCtD
Dexmedetomidine—Dermatitis—Alitretinoin—peripheral nervous system neoplasm	0.000256	0.00073	CcSEcCtD
Dexmedetomidine—Bradycardia—Epirubicin—peripheral nervous system neoplasm	0.000254	0.000727	CcSEcCtD
Dexmedetomidine—Headache—Alitretinoin—peripheral nervous system neoplasm	0.000254	0.000726	CcSEcCtD
Dexmedetomidine—Neuropathy peripheral—Doxorubicin—peripheral nervous system neoplasm	0.000252	0.000721	CcSEcCtD
Dexmedetomidine—Haemoglobin—Epirubicin—peripheral nervous system neoplasm	0.000251	0.000717	CcSEcCtD
Dexmedetomidine—Abdominal pain—Etoposide—peripheral nervous system neoplasm	0.00025	0.000715	CcSEcCtD
Dexmedetomidine—Body temperature increased—Etoposide—peripheral nervous system neoplasm	0.00025	0.000715	CcSEcCtD
Dexmedetomidine—Urinary tract infection—Doxorubicin—peripheral nervous system neoplasm	0.00025	0.000715	CcSEcCtD
Dexmedetomidine—Haemorrhage—Epirubicin—peripheral nervous system neoplasm	0.00025	0.000714	CcSEcCtD
Dexmedetomidine—Vomiting—Vincristine—peripheral nervous system neoplasm	0.000249	0.00071	CcSEcCtD
Dexmedetomidine—Rash—Vincristine—peripheral nervous system neoplasm	0.000246	0.000704	CcSEcCtD
Dexmedetomidine—Dermatitis—Vincristine—peripheral nervous system neoplasm	0.000246	0.000703	CcSEcCtD
Dexmedetomidine—Oedema peripheral—Epirubicin—peripheral nervous system neoplasm	0.000246	0.000703	CcSEcCtD
Dexmedetomidine—Headache—Vincristine—peripheral nervous system neoplasm	0.000245	0.0007	CcSEcCtD
Dexmedetomidine—Nausea—Alitretinoin—peripheral nervous system neoplasm	0.000241	0.000688	CcSEcCtD
Dexmedetomidine—Visual impairment—Epirubicin—peripheral nervous system neoplasm	0.000241	0.000688	CcSEcCtD
Dexmedetomidine—Diarrhoea—Cisplatin—peripheral nervous system neoplasm	0.000236	0.000676	CcSEcCtD
Dexmedetomidine—Bradycardia—Doxorubicin—peripheral nervous system neoplasm	0.000235	0.000672	CcSEcCtD
Dexmedetomidine—Haemoglobin—Doxorubicin—peripheral nervous system neoplasm	0.000232	0.000664	CcSEcCtD
Dexmedetomidine—Nausea—Vincristine—peripheral nervous system neoplasm	0.000232	0.000663	CcSEcCtD
Dexmedetomidine—Cardiac disorder—Epirubicin—peripheral nervous system neoplasm	0.000232	0.000662	CcSEcCtD
Dexmedetomidine—Haemorrhage—Doxorubicin—peripheral nervous system neoplasm	0.000231	0.00066	CcSEcCtD
Dexmedetomidine—Oedema peripheral—Doxorubicin—peripheral nervous system neoplasm	0.000228	0.000651	CcSEcCtD
Dexmedetomidine—Angiopathy—Epirubicin—peripheral nervous system neoplasm	0.000227	0.000648	CcSEcCtD
Dexmedetomidine—Mediastinal disorder—Epirubicin—peripheral nervous system neoplasm	0.000225	0.000643	CcSEcCtD
Dexmedetomidine—Chills—Epirubicin—peripheral nervous system neoplasm	0.000224	0.00064	CcSEcCtD
Dexmedetomidine—Arrhythmia—Epirubicin—peripheral nervous system neoplasm	0.000223	0.000638	CcSEcCtD
Dexmedetomidine—Visual impairment—Doxorubicin—peripheral nervous system neoplasm	0.000223	0.000636	CcSEcCtD
Dexmedetomidine—Vomiting—Cisplatin—peripheral nervous system neoplasm	0.00022	0.000628	CcSEcCtD
Dexmedetomidine—Mental disorder—Epirubicin—peripheral nervous system neoplasm	0.000219	0.000625	CcSEcCtD
Dexmedetomidine—Rash—Cisplatin—peripheral nervous system neoplasm	0.000218	0.000623	CcSEcCtD
Dexmedetomidine—Dermatitis—Cisplatin—peripheral nervous system neoplasm	0.000218	0.000622	CcSEcCtD
Dexmedetomidine—Malnutrition—Epirubicin—peripheral nervous system neoplasm	0.000217	0.000621	CcSEcCtD
Dexmedetomidine—Diarrhoea—Etoposide—peripheral nervous system neoplasm	0.000217	0.000619	CcSEcCtD
Dexmedetomidine—Cardiac disorder—Doxorubicin—peripheral nervous system neoplasm	0.000215	0.000613	CcSEcCtD
Dexmedetomidine—Angiopathy—Doxorubicin—peripheral nervous system neoplasm	0.00021	0.000599	CcSEcCtD
Dexmedetomidine—Dizziness—Etoposide—peripheral nervous system neoplasm	0.000209	0.000598	CcSEcCtD
Dexmedetomidine—Mediastinal disorder—Doxorubicin—peripheral nervous system neoplasm	0.000208	0.000595	CcSEcCtD
Dexmedetomidine—Chills—Doxorubicin—peripheral nervous system neoplasm	0.000207	0.000593	CcSEcCtD
Dexmedetomidine—Arrhythmia—Doxorubicin—peripheral nervous system neoplasm	0.000206	0.00059	CcSEcCtD
Dexmedetomidine—Nausea—Cisplatin—peripheral nervous system neoplasm	0.000205	0.000587	CcSEcCtD
Dexmedetomidine—Mental disorder—Doxorubicin—peripheral nervous system neoplasm	0.000203	0.000579	CcSEcCtD
Dexmedetomidine—Vomiting—Etoposide—peripheral nervous system neoplasm	0.000201	0.000575	CcSEcCtD
Dexmedetomidine—Malnutrition—Doxorubicin—peripheral nervous system neoplasm	0.000201	0.000575	CcSEcCtD
Dexmedetomidine—Anaemia—Epirubicin—peripheral nervous system neoplasm	0.000201	0.000574	CcSEcCtD
Dexmedetomidine—Agitation—Epirubicin—peripheral nervous system neoplasm	0.0002	0.000571	CcSEcCtD
Dexmedetomidine—Rash—Etoposide—peripheral nervous system neoplasm	0.0002	0.00057	CcSEcCtD
Dexmedetomidine—Dermatitis—Etoposide—peripheral nervous system neoplasm	0.000199	0.00057	CcSEcCtD
Dexmedetomidine—Headache—Etoposide—peripheral nervous system neoplasm	0.000198	0.000567	CcSEcCtD
Dexmedetomidine—Convulsion—Epirubicin—peripheral nervous system neoplasm	0.000188	0.000538	CcSEcCtD
Dexmedetomidine—Nausea—Etoposide—peripheral nervous system neoplasm	0.000188	0.000537	CcSEcCtD
Dexmedetomidine—Hypertension—Epirubicin—peripheral nervous system neoplasm	0.000188	0.000536	CcSEcCtD
Dexmedetomidine—Anaemia—Doxorubicin—peripheral nervous system neoplasm	0.000186	0.000531	CcSEcCtD
Dexmedetomidine—Agitation—Doxorubicin—peripheral nervous system neoplasm	0.000185	0.000528	CcSEcCtD
Dexmedetomidine—Anxiety—Epirubicin—peripheral nervous system neoplasm	0.000185	0.000527	CcSEcCtD
Dexmedetomidine—Dry mouth—Epirubicin—peripheral nervous system neoplasm	0.000181	0.000517	CcSEcCtD
Dexmedetomidine—Confusional state—Epirubicin—peripheral nervous system neoplasm	0.000179	0.000511	CcSEcCtD
Dexmedetomidine—Infection—Epirubicin—peripheral nervous system neoplasm	0.000176	0.000504	CcSEcCtD
Dexmedetomidine—Convulsion—Doxorubicin—peripheral nervous system neoplasm	0.000174	0.000498	CcSEcCtD
Dexmedetomidine—Thrombocytopenia—Epirubicin—peripheral nervous system neoplasm	0.000174	0.000497	CcSEcCtD
Dexmedetomidine—Hypertension—Doxorubicin—peripheral nervous system neoplasm	0.000174	0.000496	CcSEcCtD
Dexmedetomidine—Tachycardia—Epirubicin—peripheral nervous system neoplasm	0.000173	0.000495	CcSEcCtD
Dexmedetomidine—Hyperhidrosis—Epirubicin—peripheral nervous system neoplasm	0.000172	0.00049	CcSEcCtD
Dexmedetomidine—Anxiety—Doxorubicin—peripheral nervous system neoplasm	0.000171	0.000488	CcSEcCtD
Dexmedetomidine—Dry mouth—Doxorubicin—peripheral nervous system neoplasm	0.000168	0.000479	CcSEcCtD
Dexmedetomidine—Hypotension—Epirubicin—peripheral nervous system neoplasm	0.000166	0.000474	CcSEcCtD
Dexmedetomidine—Confusional state—Doxorubicin—peripheral nervous system neoplasm	0.000166	0.000473	CcSEcCtD
Dexmedetomidine—Infection—Doxorubicin—peripheral nervous system neoplasm	0.000163	0.000466	CcSEcCtD
Dexmedetomidine—Thrombocytopenia—Doxorubicin—peripheral nervous system neoplasm	0.000161	0.000459	CcSEcCtD
Dexmedetomidine—Tachycardia—Doxorubicin—peripheral nervous system neoplasm	0.00016	0.000458	CcSEcCtD
Dexmedetomidine—Hyperhidrosis—Doxorubicin—peripheral nervous system neoplasm	0.000159	0.000454	CcSEcCtD
Dexmedetomidine—Dyspnoea—Epirubicin—peripheral nervous system neoplasm	0.000158	0.000452	CcSEcCtD
Dexmedetomidine—Somnolence—Epirubicin—peripheral nervous system neoplasm	0.000158	0.000451	CcSEcCtD
Dexmedetomidine—Hypotension—Doxorubicin—peripheral nervous system neoplasm	0.000153	0.000438	CcSEcCtD
Dexmedetomidine—Gastrointestinal disorder—Epirubicin—peripheral nervous system neoplasm	0.000153	0.000438	CcSEcCtD
Dexmedetomidine—Pain—Epirubicin—peripheral nervous system neoplasm	0.000152	0.000434	CcSEcCtD
Dexmedetomidine—Constipation—Epirubicin—peripheral nervous system neoplasm	0.000152	0.000434	CcSEcCtD
Dexmedetomidine—Dyspnoea—Doxorubicin—peripheral nervous system neoplasm	0.000146	0.000418	CcSEcCtD
Dexmedetomidine—Feeling abnormal—Epirubicin—peripheral nervous system neoplasm	0.000146	0.000418	CcSEcCtD
Dexmedetomidine—Somnolence—Doxorubicin—peripheral nervous system neoplasm	0.000146	0.000417	CcSEcCtD
Dexmedetomidine—Gastrointestinal pain—Epirubicin—peripheral nervous system neoplasm	0.000145	0.000415	CcSEcCtD
Dexmedetomidine—Gastrointestinal disorder—Doxorubicin—peripheral nervous system neoplasm	0.000142	0.000405	CcSEcCtD
Dexmedetomidine—Constipation—Doxorubicin—peripheral nervous system neoplasm	0.00014	0.000401	CcSEcCtD
Dexmedetomidine—Pain—Doxorubicin—peripheral nervous system neoplasm	0.00014	0.000401	CcSEcCtD
Dexmedetomidine—Body temperature increased—Epirubicin—peripheral nervous system neoplasm	0.00014	0.000401	CcSEcCtD
Dexmedetomidine—Abdominal pain—Epirubicin—peripheral nervous system neoplasm	0.00014	0.000401	CcSEcCtD
Dexmedetomidine—Feeling abnormal—Doxorubicin—peripheral nervous system neoplasm	0.000135	0.000387	CcSEcCtD
Dexmedetomidine—Gastrointestinal pain—Doxorubicin—peripheral nervous system neoplasm	0.000134	0.000384	CcSEcCtD
Dexmedetomidine—Abdominal pain—Doxorubicin—peripheral nervous system neoplasm	0.00013	0.000371	CcSEcCtD
Dexmedetomidine—Body temperature increased—Doxorubicin—peripheral nervous system neoplasm	0.00013	0.000371	CcSEcCtD
Dexmedetomidine—Diarrhoea—Epirubicin—peripheral nervous system neoplasm	0.000121	0.000347	CcSEcCtD
Dexmedetomidine—Dizziness—Epirubicin—peripheral nervous system neoplasm	0.000117	0.000335	CcSEcCtD
Dexmedetomidine—Vomiting—Epirubicin—peripheral nervous system neoplasm	0.000113	0.000322	CcSEcCtD
Dexmedetomidine—Diarrhoea—Doxorubicin—peripheral nervous system neoplasm	0.000112	0.000321	CcSEcCtD
Dexmedetomidine—Rash—Epirubicin—peripheral nervous system neoplasm	0.000112	0.00032	CcSEcCtD
Dexmedetomidine—Dermatitis—Epirubicin—peripheral nervous system neoplasm	0.000112	0.000319	CcSEcCtD
Dexmedetomidine—Headache—Epirubicin—peripheral nervous system neoplasm	0.000111	0.000318	CcSEcCtD
Dexmedetomidine—Dizziness—Doxorubicin—peripheral nervous system neoplasm	0.000109	0.00031	CcSEcCtD
Dexmedetomidine—Nausea—Epirubicin—peripheral nervous system neoplasm	0.000105	0.000301	CcSEcCtD
Dexmedetomidine—Vomiting—Doxorubicin—peripheral nervous system neoplasm	0.000104	0.000298	CcSEcCtD
Dexmedetomidine—Rash—Doxorubicin—peripheral nervous system neoplasm	0.000104	0.000296	CcSEcCtD
Dexmedetomidine—Dermatitis—Doxorubicin—peripheral nervous system neoplasm	0.000103	0.000296	CcSEcCtD
Dexmedetomidine—Headache—Doxorubicin—peripheral nervous system neoplasm	0.000103	0.000294	CcSEcCtD
Dexmedetomidine—Nausea—Doxorubicin—peripheral nervous system neoplasm	9.75e-05	0.000279	CcSEcCtD
